(Bloomberg) — Towers Watson & Co. shareholders should vote against an $8.9 billion merger with Willis Group Holdings Plc even after the insurance broker increased the offer amid a backlash from investors, proxy adviser Glass Lewis & Co. said in a report.
The transaction remains "inappropriately structured" and Towers Watson investors should reject the deal, Glass Lewis said in an updated report published Dec. 2. Glass Lewis and Institutional Shareholder Services had earlier urged Towers Watson investors to reject the initial terms, before both companies agreed to more than double the one-time cash dividend.
Towers Watson saw investors push back after the initial deal, announced in June, valued the consulting firm at about $8.7 billion. Willis is seeking to merge with Towers Watson to compete against diversified rivals including Aon Plc and Marsh & McLennan Cos., and its investors would own about 50.1% of the combined company.
Continue Reading for Free
Register and gain access to:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
